CAST 2023 is two weeks away!

TTS will have a strong presence at CAST 2023, with numerous leaders and members from our organization in attendance.

Come and join us in Hong Kong!

John Fung
TTS President-Elect
Jeremy Chapman
Editor-in-Chief, Transplantation
Germaine Wong
TTS 2024 SPC Co-Chair
Sanjay Nagral
DICG Co-Chair
Tan Ban Hock
TID President
Curie Ahn
TTS Councilor
Vivek Kute
TTS Councilor
Dominique Martin
TTS Councilor
Xunrong Luo
Basic Science Committee Chair

Join TID in Hong Kong at CAST - August 25-28, 2023

Transplantation Journal Highlights

Transplantation - Highlighted Tweets

Primary Graft Dysfunction Is Associated With Development of Early Cardiac Allograft Vasculopathy, but Not Other Immune-mediated Complications, After Heart Transplantation
We investigated associations between primary graft dysfunction (PGD) and development of acute cellular rejection (ACR), de novo donor-specific antibodies (DSAs), and cardiac allograft vasculopathy (CAV) after heart transplantation (HT).
MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection
Although donor-specific antibody pre- and posttransplantation is routinely assessed, accurate quantification of memory alloreactive B cells that mediate recall antibody response remains challenging. Major histocompatibility complex (MHC) tetramers have been used to identify alloreactive B cells in mice and humans, but the specificity of this approach has not been rigorously assessed.

Transplantation Direct - Highlighted Tweets

Human Transplant Kidneys on Normothermic Machine Perfusion Display Endocrine Activity
Normothermic machine perfusion (NMP) is an alternative to hypothermic machine perfusion (HMP) for donor kidney preservation before transplantation. Contrary to HMP, NMP allows for functional assessment of donor kidneys because normothermic conditions allow for metabolic activity. The kidneys are key producers of hormones. Yet, it remains unknown whether donor kidneys during NMP display endocrine functions.
The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients
SHELTER is a trial of transplanting lungs from deceased donors with hepatitis C virus (HCV) infection into HCV-negative candidates (sponsor: Merck; NCT03724149). Few trials have reported outcomes using thoracic organs from HCV-RNA+ donors and none have reported quality of life (QOL).

Upcoming Webinar Presentation

ISUTx 2023 - Extended Abstract Deadline!

Abstract Submission Ends Today!

Scientific Program Now Available!

SPLIT 2023 - Submit Your Abstract!

Abstract Submission Ends August 15!

We welcome leading experts and opinion leaders from all over the world to present their latest data and address important needs in clinical pediatric liver transplant and hosting sessions devoted to emerging research in the field.

Reminder 2023 Proposed TTS By-law Changes

Deadline to submit your ballot is October 21, 2023

TTS Council is pleased to present eight proposed By-law amendments to aid in shaping the future of the Society.

Among the changes proposed are expansion of Council to increase diversity, ensuring female, early career and Middle East AND Africa countries representation.

TTS encourages all full members to actively participate by voting before the ballot closes September 21.

To review the proposed by-law amendments and the rationale statements please click the link below.

If you are a TTS full member you should have received an e-mail with your personalized voting link today. Alternatively you may use the link above to submit your ballot.

In the News 

Opinion - Dismantling the organ sharing network will bring catastrophic ramifications for patients

Aug. 10 - When Congress created the OPTN by passing the National Organ Transplant Act of 1984, they included a requirement that only nonprofit groups may lead it under contract with the Health Resources and Services Administration (HRSA). This was based on government-sponsored research performed by a team of experienced surgeons, scientists, lawyers and ethicists. Their reasoning, which is even more valid today than it was in the 1980s, was that we cannot have a truly equitable transplant system if profits are allowed to be a motivating factor in the OPTN’s work. Sure enough, today the OPTN’s organ matching, policymaking and other responsibilities are guided by whether they would help the sickest, most medically urgent patients.

Islet Allogeneic Transplantation in Type 1 Diabetes: Assessing 5-Year Outcomes and Primary Graft Function

Aug. 3 - Allogeneic islet transplantation is a validated treatment for type 1 diabetes; however, transplanted islet graft function declines over time for unknown reasons. Researchers investigated the relationship between primary graft function (PGF) and 5-year islet transplantation outcomes. In this retrospective, multicenter, observational cohort study, researchers enrolled all patients from the Collaborative Islet Transplant Registry who received islet transplantation alone (ITA recipients) or islet-after-kidney transplantation (IAK recipients) between January 19, 1999, and July 17, 2020, and had a calculable PGF (exposure of interest) measured 28 days after the last islet infusion using a validated composite index of islet graft function (BETA-2 score).



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6